Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TIA1 Antikörper (AA 279-380)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch TIA1 in WB, IF und FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7127001

Kurzübersicht für TIA1 Antikörper (AA 279-380) (ABIN7127001)

Target

Alle TIA1 Antikörper anzeigen
TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

Reaktivität

  • 75
  • 30
  • 30
  • 5
  • 5
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 58
  • 16
  • 1
Maus

Klonalität

  • 50
  • 25
Monoklonal

Konjugat

  • 36
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TIA1 Antikörper ist unkonjugiert

Applikation

  • 43
  • 22
  • 18
  • 17
  • 14
  • 13
  • 10
  • 9
  • 6
  • 5
  • 5
  • 3
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
  • Bindungsspezifität

    • 15
    • 9
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 279-380

    Spezifität

    TIA-1 (T-cell intracytoplasmic antigen) is a cytoplasmic granule-associated protein, expressed in lymphocytes processing cytolytic potential. TIA-1 is a member of an RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15 kDa protein thought to be derived from the carboxyl terminus of the 40 kDa product by proteolytic processing. TIA1 antibody labels cytotoxic T cells and natural killer cells (NK cells). It is also expressed in T-cell lymphoma, large granular lymphocyte (LGL) leukemia and hairy cell leukemia. TIA1 expression in T-cell malignancies may help in differentiating LGL leukemia (high expression) from T-cell lymphocytosis and other T-cell diseases (low expression). TIA1 may also be used to label tumor-infiltrating lymphocytes in the study of immune response to malignancies.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human TIA1 fragment of 102 amino acid residues (aa279-380)

    Isotyp

    IgG2b
  • Applikationshinweise

    Known_Application: Flow Cytometry (0.5-1 μg/million cells in 0.1ml), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL for 60 minutes at RT),Optimal dilution for a specific application should be determined.

    Positive_Control: HepG2, PC3 or HeLa cells. Human tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

    Andere Bezeichnung

    TIA1

    Hintergrund

    Cytotoxic granule associated RNA binding protein 1, mTIA-1, Nucleolysin TIA1 isoform p40, p40-TIA-1, RNA binding protein TIA1, T-cell-restricted intracellular antigen-1 (TIA1), TIA-1, TIA1, TIA1 cytotoxic granule associated RNA binding protein, TIAL1, TIAR, WDM,TIA1 (T-Cell-Restricted Intracellular Antigen-1)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    40kDa

    Gen-ID

    7072, 413123

    UniProt

    P31483
Sie sind hier:
Chat with us!